Subsidiary of Shandong Oriental Ocean Sci-tech (002086.SZ) obtains a medical device registration certificate.
Oriental Ocean (002086.SZ) announced that its wholly-owned subsidiary, Avik BioTech Co., Ltd., has independently developed a procalcitonin (PCT) detection reagent kit (fluorescent immunoassay method), which has recently obtained the registration approval from the Shandong Provincial Drug Administration, and has obtained a medical device registration certificate. The above-mentioned product has been approved for listing, further enriching Avik BioTech Co., Ltd.'s product line in the clinical testing field.
Shandong Oriental Ocean Sci-tech (002086.SZ) announced that its wholly-owned subsidiary, AVIC Biotechnology Co., Ltd., has independently developed a Procalcitonin (PCT) detection kit (fluorescent immunochromatography method) which recently obtained registration approval from the Shandong Provincial Food and Drug Administration, obtaining a medical device registration certificate. The above-mentioned product has been approved for market launch, further enriching AVIC Biotechnology Co., Ltd.'s product line in the field of clinical testing.
Related Articles
Jiangsu Lettall Electronic (603629.SH) has been approved to register 500 million yuan in mid-term notes.
ASCLETIS-B (01672) spent 2.4937 million Hong Kong dollars to repurchase 200,000 shares on December 22nd.
C-MER MEDICAL (03309) repurchased 250,000 shares at a cost of 417,500 Hong Kong dollars on December 22nd.
Jiangsu Lettall Electronic (603629.SH) has been approved to register 500 million yuan in mid-term notes.
ASCLETIS-B (01672) spent 2.4937 million Hong Kong dollars to repurchase 200,000 shares on December 22nd.
C-MER MEDICAL (03309) repurchased 250,000 shares at a cost of 417,500 Hong Kong dollars on December 22nd.
